Kase F, Pospísil J, Hlousková D
Folia Haematol Int Mag Klin Morphol Blutforsch. 1985;112(6):809-30.
The mutual relationships between malignant tumours and mechanisms of blood coagulation are presented in a brief survey. In this connection, the mechanisms of a tumour cell entering the circulation through the vessel well and its leaving into the tissues are discussed, the theory of microtrauma being used for explaining these processes. Subsequently, the alterations to be found in the count and function of thrombocytes after contact with a malignant cell and the impact on this cell by blood platelets are represented. As a third factor the activation of blood coagulation which is exercised by substances with a procoagulatory effect produced by the malignant tissue and the frequently observed thrombosis in the course of neoplastic diseases are dealt with in connection with blood level changes of some coagulation factors. In a fourth section the significance of fibrinolysis, its activation and inhibition as well as the production of fibrinolytic activators by neoplasms are discussed.
本文简要综述了恶性肿瘤与血液凝固机制之间的相互关系。就此,讨论了肿瘤细胞通过血管壁进入循环并进入组织的机制,采用微创伤理论来解释这些过程。随后,阐述了与恶性细胞接触后血小板数量和功能的变化以及血小板对该细胞的影响。作为第三个因素,探讨了由恶性组织产生的具有促凝作用的物质所引发的血液凝固激活以及肿瘤疾病过程中常见的血栓形成与某些凝血因子血液水平变化的关系。在第四部分中,讨论了纤维蛋白溶解的意义、其激活和抑制以及肿瘤产生纤维蛋白溶解激活剂的情况。